2018 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Report - History, Present and Future

November 2018 | 147 pages | ID: 237A85554AAPEN
Prof Research

Abstracts

The global market size of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:

• North America
• South America
• Asia & Pacific
• Europe
• MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) as well as some small players. The compnaies include:

Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee, Fluxion, Gilupi et al.

The information for each competitor includes:

• Company Profile
• Main Business Information
• SWOT Analysis
• Sales, Revenue, Price and Gross Margin
• Market Share

We also can offer customized report to fulfill special requirements of our clients.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Region
8.2 Import of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT CIRCULATING TUMOR CELLS (CTCS) AND CANCER STEM CELLS (CSCS) MARKET IN NORTH AMERICA (2013-2018)

9.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply
9.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT CIRCULATING TUMOR CELLS (CTCS) AND CANCER STEM CELLS (CSCS) MARKET IN SOUTH AMERICA (2013-2018)

10.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply
10.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT CIRCULATING TUMOR CELLS (CTCS) AND CANCER STEM CELLS (CSCS) MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply
11.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT CIRCULATING TUMOR CELLS (CTCS) AND CANCER STEM CELLS (CSCS) MARKET IN EUROPE (2013-2018)

12.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply
12.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT CIRCULATING TUMOR CELLS (CTCS) AND CANCER STEM CELLS (CSCS) MARKET IN MEA (2013-2018)

13.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply
13.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL CIRCULATING TUMOR CELLS (CTCS) AND CANCER STEM CELLS (CSCS) MARKET (2013-2018)

14.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply
14.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL CIRCULATING TUMOR CELLS (CTCS) AND CANCER STEM CELLS (CSCS) MARKET FORECAST (2019-2023)

15.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply Forecast
15.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE(JANSSEN, QIAGEN, ADVANCED CELL DIAGNOSTICS, APOCELL, BIOFLUIDICA, CLEARBRIDGE BIOMEDICS, CYTOTRACK, CELSEE, FLUXION, GILUPI ET AL.)

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2013-2018)

Tables & Figures

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Report
Table Primary Sources of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Report
Table Secondary Sources of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Report
Table Major Assumptions of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Report
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Picture
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Classification
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Applications List
Table Drivers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market
Table Restraints of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market
Table Opportunities of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market
Table Threats of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market
Table Key Raw Material of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) and Its Suppliers
Table Key Technologies of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table Cost Structure of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table Market Channel of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Application and Key End Users List
Table Latest News of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry
Table Recently Merger and Acquisition List of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry
Table Recently Planned/Future Project List of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry
Table Policy Dynamics Update of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry
Table 2013-2023 Export of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Region
Table 2013-2023 Import of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Region
Table 2013-2023 Balance of Trade of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure 2013 2018 and 2023 Global Trade Map of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table 2013-2018 North America Supply of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure 2013-2018 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply and GAGR
Table 2013-2018 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand List
Figure 2013-2018 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand by Type
Figure 2013-2018 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price
Table 2013-2018 Key Countries Supply of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure 2013-2018 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply and GAGR
Table 2013-2018 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand List
Figure 2013-2018 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand by Type
Figure 2013-2018 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price
Table 2013-2018 Key Countries Supply of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure 2013-2018 Asia & Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply and GAGR
Table 2013-2018 Asia & Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand List
Figure 2013-2018 Asia & Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand by Type
Figure 2013-2018 Asia & Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price
Table 2013-2018 Key Countries Supply of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure 2013-2018 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply and GAGR
Table 2013-2018 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand List
Figure 2013-2018 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand by Type
Figure 2013-2018 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price
Table 2013-2018 Key Countries Supply of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure 2013-2018 MEA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Supply and GAGR
Table 2013-2018 MEA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand List
Figure 2013-2018 MEA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand by Type
Figure 2013-2018 MEA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price
Table 2013-2018 Key Countries Supply of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Region
Figure 2013-2018 Global Supply and CAGR of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Region
Table 2013-2018 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand List by Region
Figure 2013-2018 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type-wise Demand by Region
Figure 2013-2018 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price
Table Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Revenue and Growth Rate
Figure 2013-2018 Company A Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share
Table Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Revenue and Growth Rate
Figure 2013-2018 Company B Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share
Table Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Revenue and Growth Rate
Figure 2013-2018 Company C Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share
Table Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Revenue and Growth Rate
Figure 2013-2018 Company D Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share
Table Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Revenue and Growth Rate
Figure 2013-2018 Company E Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share
Table Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Revenue and Growth Rate
Figure 2013-2018 Company F Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share
Table Main Business and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Revenue and Growth Rate
Figure 2013-2018 Company G Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share